Ripretinib is a targeted cancer therapy used to treat gastrointestinal stromal tumors (GISTs) that are resistant to other treatments. It works by inhibiting multiple tyrosine kinases involved in the growth and survival of cancer cells. Ripretinib is used in patients with advanced or metastatic GIST who have failed other therapies.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Ripretinib and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Ripretinib impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Ripretinib-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
